benzgalantamine
benzgalantamine is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand name including ZUNVEYL. Available dosage form: tablet, delayed release.
Drug Details
- Generic Name
- benzgalantamine
- Brand Names
- ZUNVEYL
- Application Number
- NDA218549
- Sponsor
- Alpha Cognition, Inc.
- NDC Codes
- 3
- Dosage Forms
- TABLET, DELAYED RELEASE
- Routes
- ORAL
- Active Ingredients
- BENZGALANTAMINE
Indications and Usage
1 INDICATIONS AND USAGE ZUNVEYL is indicated for the treatment of mild to moderate dementia of the Alzheimer's type in adults. ZUNVEYL is a cholinesterase inhibitor indicated for the treatment of mild to moderate dementia of the Alzheimer's type in adults ( 1 )